Target intelligence / Profile preview

Reactive oxygen species–autophagy axis (ROS–autophagy axis)

Target
ROS–autophagy axis
Molecular classification
Other
01

Overview

The Reactive oxygen species (ROS)–autophagy axis represents a complex regulatory feedback loop where ROS serve as key signaling molecules to initiate or modulate autophagic activity. Under conditions of oxidative stress, ROS can activate autophagy through various mechanisms, including the regulation of Atg proteins, the inhibition of the mTOR pathway, or the activation of the AMPK pathway (Filomeni et al., 2015, Trends in Molecular Medicine). This axis is fundamental for maintaining cellular quality control by facilitating the degradation of damaged mitochondria (mitophagy) and oxidized proteins, thereby preventing further ROS accumulation. In the context of disease, the ROS–autophagy axis is often dysregulated; in cancer, it can act as a double-edged sword, either promoting tumor cell survival under metabolic stress or inducing autophagic cell death (Scherz-Shouval & Elazar, 2011, Antioxidants & Redox Signaling). Pharmacological intervention targeting this axis includes the use of antioxidants like N-acetylcysteine to reduce ROS-driven autophagy or autophagy modulators like Rapamycin and Chloroquine to alter the downstream response (Li et al., 2012, Autophagy).

Other names
ROS-induced autophagyOxidative stress-autophagy pathwayRedox-autophagy signaling
02

Mechanism of action

Modulation of intracellular redox state and autophagic flux to restore cellular homeostasis or induce programmed cell death.

03

Biological functions

Signal transductionCell deathOther
04

Disease associations

CancerNeurodegenerative diseaseCardiovascular diseaseInfection
05

Safety considerations

Context-dependent biological outcomes (pro-survival vs. pro-death)Potential for systemic toxicity with broad autophagy inhibitorsRisk of neurotoxicity due to impairment of basal autophagyInterference with normal redox signaling
06

Interacting drugs

Rapamycin

5 more in the full profile.

07

Biomarkers

LC3-II/LC3-I ratiop62 (SQSTM1) protein levelsReactive oxygen species (ROS) levelsMalondialdehyde (MDA)Superoxide dismutase (SOD)

Beyond the preview

Go deeper on Reactive oxygen species–autophagy axis (ROS–autophagy axis).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Reactive oxygen species–autophagy axis (ROS–autophagy axis).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call